PTP
DCOY

Platform Technology Partners’s Decoy Therapeutics DCOY Stock Holding History

Platform Technology Partners’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$36K Buy
+1
New +$29.3K 0.02% 233

Other funds holding DCOY

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DWA
Douglass Winthrop Advisors New York $5.8B AUM 11.8% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LNWWM
Laird Norton Wetherby Wealth Management San Francisco, California $2.45B AUM

Platform Technology Partners's DCOY Position: Q4 2020 in Review

Platform Technology Partners opened a new position in Decoy Therapeutics (DCOY) in Q4 2020: 1 share worth $36K. The stake represents 0.02% of the portfolio and ranks #233 among its holdings.

14 funds tracked by Wall St. Rank hold DCOY as of Q4 2020.

  • Platform Technology Partners held 1 share of Decoy Therapeutics worth $36K as of Q4 2020.
  • Decoy Therapeutics was a new Platform Technology Partners position in Q4 2020.
  • Decoy Therapeutics made up 0.02% of Platform Technology Partners's portfolio in Q4 2020, its #233 holding.
  • 14 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q4 2020.

Based on Platform Technology Partners's 13F filing for Q4 2020, filed 9 Feb 2021.